{"product_id":"in-situ-hybridization-ish","title":"In Situ Hybridization (ISH)","description":"\u003cp\u003eIn Situ Hybridization (ISH)\u003cbr\u003e\nGlobal In Situ Hybridization (ISH) Market to Reach $1.5 Billion  by 2030\u003cbr\u003e\nThe global market for In Situ Hybridization (ISH) estimated at US$908 Million in the year 2022, is projected to reach a revised size of US$1.5 Billion by 2030, growing at a CAGR of 6.6% over the period 2022-2030. Fluorescence In Situ Hybridization (FISH), one of the segments analyzed in the report, is projected to record 6.4% CAGR and reach US$1.1 Billion by the end of the analysis period. Growth in the Chromogenic In Situ Hybridization (CISH) segment is estimated at 7% CAGR for the next 8-year period.\u003c\/p\u003e\n\n\u003cp\u003eThe U.S. Market is Estimated at $377.5 Million, While China is Forecast to Grow at 8% CAGR\u003cbr\u003e\nThe In Situ Hybridization (ISH) market in the U.S. is estimated at US$377.5 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$107.4 Million by the year 2030 trailing a CAGR of 8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.7% and 6.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 6.5% CAGR.Select Competitors (Total 38 Featured) - Abbott Laboratories, Inc.Agilent Technologies, Inc.Bio-Rad Laboratories, Inc.BioGenexAbnova CorporationBio-Techne CorporationBiocare Medical LLCLeica Biosystems Nussloch GmbHAdvanced Cell Diagnostics, Inc.Empire Genomics LLCBiodot, Inc.IMRIS, Deerfield Imaging, Inc.Creative BiolabsBio SbGuangzhou Ruibo Biotechnology Co., Ltd.Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.\u003c\/p\u003e \n\n\u003cp\u003eThe latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.\u003c\/p\u003e \n\n\u003cp\u003ePrior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"September, 2023 \/ 504 Pages \/ MCW16232310","offer_id":47647491490098,"sku":null,"price":5940.0,"currency_code":"USD","in_stock":true},{"title":"September, 2023 \/ 504 Pages \/ MCW16232311","offer_id":47647491522866,"sku":null,"price":5940.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/in-situ-hybridization-ish","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}